blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2288340

EP2288340 - NANOPARTICLE FORMULATIONS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.04.2021
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  22.05.2020
FormerGrant of patent is intended
Status updated on  09.10.2019
FormerExamination is in progress
Status updated on  03.05.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Abraxis BioScience, LLC
86 Morris Avenue
Summit, NJ 07901 / US
[2018/15]
Former [2011/52]For all designated states
Abraxis BioScience, LLC
11755 Wilshire Boulevard
Suite 2100
Los Angeles, CA 90025 / US
Former [2011/09]For all designated states
Abraxis BioScience, LLC
11755 Wilshire Boulevard Suite 2000
Los Angeles, CA 90025 / US
Inventor(s)01 / DESAI, Neil, P.
1343 Luna Vista Drive
Pacific Palisades, CA 90272 / US
02 / TAO, Chunlin
c/o Abraxis BioScience, LLC
86 Morris Avenue
Summit, NJ 07901 / US
03 / DE, Tapas
10927 Palms Boulevard Apt. 2
Los Angeles CA 90034 / US
04 / CI, Sherry, Xiaopei
1987 San Salvatore Place
San Marino CA 91108 / US
05 / TRIEU, Vuong
4003 Jim Bowie
Agoura Hills, CA 91301 / US
 [2020/12]
Former [2011/09]01 / DESAI, Neil, P.
11755 Wilshire Boulevard 20th Floor
Los Angeles CA 90025 / US
02 / TAO, Chunlin
1800 Camden Avenue Suite 301
Los Angeles CA 90025 / US
03 / DE, Tapas
10927 Palms Boulevard Apt. 2
Los Angeles CA 90034 / US
04 / CI, Sherry, Xiaopei
1987 San Salvatore Place
San Marino CA 91108 / US
05 / TRIEU, Vuong
3965 N. Ceanothus Place, H
Calabasas CA 91302 / US
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Gewürzmühlstraße 11
80538 München / DE
[N/P]
Former [2020/26]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
Former [2011/29]Weber, Martin, et al
Jones Day Rechtsanwälte Attorneys-at-Law Patentanwälte Prinzregentenstrasse 11
80538 München / DE
Former [2011/09]Roques, Sarah Elizabeth
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date09729316.110.04.2009
[2011/09]
WO2009US40281
Priority number, dateUS20080044006P10.04.2008         Original published format: US 44006 P
US20080096664P12.09.2008         Original published format: US 96664 P
[2011/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009126938
Date:15.10.2009
Language:EN
[2009/42]
Type: A1 Application with search report 
No.:EP2288340
Date:02.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.10.2009 takes the place of the publication of the European patent application.
[2011/09]
Type: B1 Patent specification 
No.:EP2288340
Date:24.06.2020
Language:EN
[2020/26]
Search report(s)International search report - published on:EP15.10.2009
ClassificationIPC:A61K9/19, A61K9/51, A61K31/337
[2011/09]
CPC:
A61K9/19 (EP,US); A61K9/14 (US); A61K31/337 (EP,US);
A61K47/42 (US); A61K9/107 (US); A61K9/5169 (EP,US);
A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2020/26]
Former [2011/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:NANOTEILCHEN-FORMULIERUNGEN UND IHRE VERWENDUNGEN[2011/09]
English:NANOPARTICLE FORMULATIONS AND USES THEREOF[2011/09]
French:FORMULATIONS DE NANOPARTICULES ET UTILISATIONS DE CELLES-CI[2011/09]
Entry into regional phase10.11.2010National basic fee paid 
10.11.2010Designation fee(s) paid 
10.11.2010Examination fee paid 
Examination procedure10.11.2010Examination requested  [2011/09]
07.03.2011Amendment by applicant (claims and/or description)
13.07.2012Despatch of a communication from the examining division (Time limit: M04)
23.11.2012Reply to a communication from the examining division
17.03.2015Despatch of a communication from the examining division (Time limit: M04)
27.07.2015Reply to a communication from the examining division
24.04.2017Despatch of a communication from the examining division (Time limit: M04)
21.08.2017Reply to a communication from the examining division
07.11.2018Despatch of a communication from the examining division (Time limit: M04)
06.03.2019Reply to a communication from the examining division
10.10.2019Communication of intention to grant the patent
10.02.2020Fee for grant paid
10.02.2020Fee for publishing/printing paid
26.03.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
18.05.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20181426.6   Application refused  : 10.11.2020
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.07.2012
Opposition(s)25.03.2021No opposition filed within time limit [2021/22]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
18.05.2020Request for further processing filed
18.05.2020Full payment received (date of receipt of payment)
Request granted
27.05.2020Decision despatched
Fees paidRenewal fee
12.04.2011Renewal fee patent year 03
25.04.2012Renewal fee patent year 04
29.04.2013Renewal fee patent year 05
28.04.2014Renewal fee patent year 06
27.04.2015Renewal fee patent year 07
27.04.2016Renewal fee patent year 08
27.04.2017Renewal fee patent year 09
27.04.2018Renewal fee patent year 10
29.04.2019Renewal fee patent year 11
30.03.2020Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.04.2009
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
MK24.06.2020
MT24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
TR24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
[2024/41]
Former [2024/29]HU10.04.2009
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
MK24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
TR24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2024/22]HU10.04.2009
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
MK24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2023/27]HU10.04.2009
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2023/24]AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2022/23]AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2022/10]AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
PT26.10.2020
Former [2021/50]AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/36]AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/20]AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/10]AT24.06.2020
CZ24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
NL24.06.2020
PL24.06.2020
RO24.06.2020
SE24.06.2020
SK24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/09]AT24.06.2020
CZ24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
NL24.06.2020
RO24.06.2020
SE24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
PT26.10.2020
Former [2021/04]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
NL24.06.2020
SE24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
Former [2021/01]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
SE24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
Former [2020/50]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
SE24.06.2020
NO24.09.2020
GR25.09.2020
Former [2020/48]FI24.06.2020
LT24.06.2020
SE24.06.2020
NO24.09.2020
Former [2020/47]LT24.06.2020
NO24.09.2020
Cited inInternational search[XI] WO2006089207  (AMERICAN BIOSCIENCE INC et al.) [X] 1-22,27,33,35,38-46,48,50-77 * examples 1,2 * * examples 11,12 *[I] 23-26,28-32,34,36-37,47,49
 [XI] US6749868  (DESAI NEIL P et al.) [X] 1-6,51-77 * example 6 * * column 1, line 20 - line 44 * * column 2, line 52 - column 3, line 36 *[I] 6-9
 [XI] WO2006091780  (ELAN PHARMA INT LTD et al.) [X] 1-6,51-77 * page 1, paragraph 1 * * example 18 * * claims 1-30 *[I] 6-9
 [Y] WO9710234  (LIPOSOME CO INC et al.) [Y] 1-77 * the whole document *
 [Y] US2004024051  (HOLTON ROBERT A et al.) [Y] 1-77 * the whole document *
 [Y]   ALI S ET AL: "Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities", ANTI-CANCER DRUGS, RAPID COMMUNICATIONS, OXFORD, vol. 12, no. 2, 1 February 2001 (2001-02-01), pages 117 - 128, XP009103673, ISSN: 0959-4973 [Y] 1-67 * the whole document *

DOI:   http://dx.doi.org/10.1097/00001813-200102000-00004
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.